Preclinical Efficacy of Pro- and Anti-Angiogenic Peptide Hydrogels to Treat Age-Related Macular Degeneration.

Acevedo-Jake, Amanda; Shi, Siyu; Siddiqui, Zain; Sanyal, Sreya; Schur, Rebecca; Kaja, Simon; Yuan, Alex; Kumar, Vivek A

Acevedo-Jake, Amanda; Shi, Siyu; Siddiqui, Zain; Sanyal, Sreya; Schur, Rebecca; Kaja, Simon; Yuan, Alex; Kumar, Vivek A.

Afiliação

Acevedo-Jake A; Department of Biomedical Engineering, New Jersey Institute of Technology, Newark, NJ 07102, USA.
Shi S; Stanford School of Medicine, Stanford University, Stanford, CA 94305, USA.
Siddiqui Z; Department of Biomedical Engineering, New Jersey Institute of Technology, Newark, NJ 07102, USA.
Sanyal S; Department of Biology, New Jersey Institute of Technology, Newark, NJ 07102, USA.
Schur R; Cole Eye Institute, Cleveland Clinic Lerner College of Medicine, Cleveland, OH 44195, USA.
Kaja S; Research & Development Division, Experimentica Ltd., 70211 Kuopio, Finland.
Yuan A; Department of Ophthalmology, Loyola University Chicago, Maywood, IL 60153, USA.
Kumar VA; Cole Eye Institute, Cleveland Clinic Lerner College of Medicine, Cleveland, OH 44195, USA.

Bioengineering (Basel) ; 8(12)2021 Nov 23.

Article em En | MEDLINE | ID: mdl-34940343

Palavras-chave

anti-angiogenic; biomaterials; hydrogel; multi-functional scaffolds; pro-angiogenic; tissue regeneration; wet age-related macular degeneration

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Bioengineering (Basel) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google